There are no News articles available at this time. Please check again soon.
Established in 1982, the Heart Transplant Program at the Texas Heart Institute at St. Luke’s Episcopal Hospital is one of the most experienced, successful programs in the world. Our surgeons have performed more than 1,100 transplant procedures. The key to the program’s success is an experienced, highly skilled transplant team that includes surgeons, cardiologists, transplant coordinators, staff nurses, operating room personnel, social workers, dieticians, rehabilitation specialists, and many other professionals.
In 1968, Denton A. Cooley and his team performed the first heart transplant in the United States and implanted the first artificial heart at St. Luke's Episcopal Hospital. Learn more about the St. Luke's Cooley Transplant Center.
MILESTONES
1968
First successful heart transplantation in the United States
1969
First implantation in the world of an artificial heart in a human
1975
First study funded buy the National Heart, Lung and Blood Institute of an implantable left ventricular assist device (LVAD) for post-cardiotomy support
1978
First bridge-to-transplant with an LVAD
1981
Second implantation in the world of an artificial heart in a human
1991
First patient in the world left the hospital with an electric, portable, battery-powered LVAD
1994
FDA approval to use the HeartMate pneumatic LVAD as a bridge to transplantation
1996
FDA approval to use the electric HeartMate as a bridge to transplantation
2000
First site for clinical trials of the Jarvik 2000, a miniature, axial flow left ventricular assist device
2001
Completed REMATCH study, which compared long-term implantation of the HeartMate electric LVAD to conventional medical therapy for heart failure
2002
HeartMate electric LVAD approved for destination therapy
2003
First implantation of a HeartMate II LVAD in the United States
2004
First United States patient to receive HeartMate II LVAD surpasses one year of survival with the device
2006
1,000th heart transplant performed
2008
HeartMate II Left Ventricular Assist System (LVAS) received FDA approval as a bridge-to-transplant (BTT) treatment option for patients suffering from advanced-stage heart failure
